Cato Mørk
Department of Dermatology
The National Hospital
University of Oslo
Norway
Name/email consistency: high
- The prostaglandin E1 analog misoprostol reduces symptoms and microvascular arteriovenous shunting in erythromelalgia-a double-blind, crossover, placebo-compared study. Mørk, C., Salerud, E.G., Asker, C.L., Kvernebo, K. J. Invest. Dermatol. (2004)
- Impaired neurogenic control of skin perfusion in erythromelalgia. Mørk, C., Kalgaard, O.M., Kvernebo, K. J. Invest. Dermatol. (2002)
- Reduced skin capillary density during attacks of erythromelalgia implies arteriovenous shunting as pathogenetic mechanism. Mørk, C., Kvernebo, K., Asker, C.L., Salerud, E.G. J. Invest. Dermatol. (2002)
- The Norwegian version of the dermatology life quality index: a study of validity and reliability in psoriatics. Mørk, C., Wahl, A., Moum, T. Acta Derm. Venereol. (2002)
- Erythromelalgia in a patient with AIDS. Mørk, C., Kalgaard, O.M., Myrvang, B., Kvernebo, K. J. Eur. Acad. Dermatol. Venereol (2000)